1334P Activity of first line immunotherapy or chemo-immunotherapy in advanced NSCLC with SMARCA4 deficiency

Autor: Grecea, A.M., Ghigna, M.R., Marinello, A., Remon Masip, J., Vasseur, D., Meyer, M-L., Soldato, D., Lavaud, P., Gazzah, A., Abdayem, P., Frelaut, M., Kasraoui, I., Garcia, C.A., Botticella, A., Levy, A., Scoazec, J-Y., Barlesi, F., Planchard, D., Besse, B., Aldea, M.

Publikováno v: In Annals of Oncology October 2023 34 Supplement 2:S769-S769

1643P - Pazopanib in advanced or metastatic synovial sarcoma: The Gustave Roussy experience

Autor: Sroussi, M., De Percin, S., Grecea, A.M., Benderra, M.A., Velev, M., Akla, S., Lezghed, N., Dumont, S., Le Péchoux, C., Honore, C., Haddag, L., Faron, M., Terrier, P., Mir, O., Le Cesne, A.

Publikováno v: In Annals of Oncology October 2018 29 Supplement 8

145P Everolimus for the treatment of thymic epithelial tumors (TETs): A real-world experience.

Autor: Florez Arango, J.D.¹ (AUTHOR), Benitez Montanez, J.C.² (AUTHOR), Botticella, A.³ (AUTHOR), Aldea, M.¹ (AUTHOR), Le Pechoux, C.⁴ (AUTHOR), Grecea, A.M.⁵ (AUTHOR), Levy, A.⁶ (AUTHOR), Roux, C.⁷ (AUTHOR), Frelaut, M.² (AUTHOR), Mussot, S.⁷ (AUTHOR), Mercier, O.⁷ (AUTHOR), Fadel, E.⁷ (AUTHOR), Scoazec, J-Y.⁸ (AUTHOR), Planchard, D.⁷ (AUTHOR), Barlesi, F.¹ (AUTHOR), Besse, B.⁹ (AUTHOR)

Publikováno v: Annals of Oncology. 2022 Supplement 8, Vol. 33, pS1429-S1429. 1p.